NOTIZIE E RICERCA
Un unico blog, con notizie nella lingua originale delle fonti. Gli articoli storici non rappresentano necessariamente le indicazioni cliniche attuali.
Provectus Pharmaceuticals, Inc. (OTCBB:PVCT, https://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, announces that data from its Phase 2 PV-10 metastatic melanoma study will
Read article ↗La Provectus ha annunciato che il 12 Novembre 2011 al 2011 International Melanoma Congress, Tampa, Florida, durante il 5th Meeting of Interdisciplinary Melanoma/Skin Cancer
Read article ↗A protein called fascin play a critical transformation role in TGF beta mediated tumor metastasis, say researchers at Moffitt Cancer Center in Tampa, In
Read article ↗Secondo lo studio eseguito da Shengyu Yang, Ph.D., del Moffitt’s Comprehensive Melanoma Research Center and the Department of Tumor Biology di Tampa, in Florida
Read article ↗Vemurafenib (Zelboraf ™) e ipilimumab saranno utilizzati insieme nella terapia del melanoma maligno metastatico, i due farmaci approvati dall’ FDA quest’anno per la terapia
Read article ↗After controversies regarding which are the best surgical excision margins for skin melanomas thicker than 2 mm, a study published Online First by The
Read article ↗ADVERTISEMENT
ADVERTISEMENT